Nitric oxide (NO)-induced relaxation is assodated with increased levels ofcGMP in vascular smooth muscle cells. However, the mechanism by which cGMP causes relaxation is unknown. This study tested the hypothesis that activation of Ca-sensitive K (Kc.) chanels, mediated by a cGMPdependent protein kinase, is responsible for the relaxation occurring in response to cGMP. In rat pulmonary artery rings, cGMP-dependent, but not cGMP-independent, relaxation was inhibited by tetraethylammonium, a classical K-channel blocker, and charybdotoxin, an inhibitor of Kca channels. Increasing extrcellular K concentration also inhibited cGMPdependent relaxation, without reducing vascular smooth muscle cGMP levels. In whole-cell patch-clamp experiments, NO and cGMP increased whole-cell K current by activating Kc. channels. This effect was mimicked by intracellular administration of (Sp)-guanosine cyclic 3',5'-phosphorothioate, a preferential cGMP-dependent protein kinase activator. Okadaic acid, a phosphatase inhibitor, enhanced whole-cell K current, consistent with an important role for channel phosphorylation in the activation of NO-responsive Kc channels. Thus NO and cGMP relax vascular smooth muscle by a cGMP-dependent protein kinase-dependent activation of K channels. This suggests that the final common pathway shared by NO and the nitrovasodilators is cGMP-dependent K-channel activation.
nitrovasodilators is cGMP-dependent K-channel activation.
Nitric oxide (NO) and nitrovasodilators cause vasodilatation by activating guanylate cyclase and increasing cGMP in vascular smooth muscle (VSM) (1) . The mechanism by which cGMP reduces vascular tone has been uncertain. Several experiments suggest that cGMP-mediated vasodilation is associated with changes in membrane potential. (i) KCl, which depolarizes VSM cells, inhibits endothelium-dependent vasodilatation (2) . (ii) NO itself hyperpolarizes VSM in many (3) (4) (5) , but not all (6, 7) , studies. Finally, agents that increase cGMP can activate K channels (8) (9) (10) . K-channel activity is the main determinant of membrane potential, and K efflux resulting from K-channel opening causes hyperpolarization, inhibits voltage-gated Ca channels, and promotes relaxation (Fig. 1) .
The current investigation evaluated two hypotheses: (i) K-channel activation is essential for cGMP-induced VSM relaxation and (ii) increases in cGMP activate K channels by stimulating cGMP-dependent protein kinase (cGK).
To precisely characterize the role of NO/cGMP-activated K channels in vascular relaxation, it is necessary to combine studies of vascular tone [isolated pulmonary artery (PA) rings] and electrophysiology (whole-cell patch-clamp studies of PA VSM). These studies prove that NO and agents that increase cGMP cause relaxation in large part by a cGKmediated activation of Ca-sensitive K (Kca) channels.
MATERIALS AND METHODS
Drugs. Drugs and reagents were from Sigma and were dissolved in normal saline unless otherwise stated. Bath concentrations of solvents were <0.1% and all vehicles were tested to exclude nonspecific effects. Saturated NO solutions (2-3 mM) were prepared and concentrations were determined as described (11) .
Vascular Rings. Second-division PA rings were dissected from adult male specific-pathogen-free Sprague-Dawley rats anesthetized with Nembutal (50 mg/kg i.p.) and mounted at a resting tension of800 mg in Earle's solution (12) . Rings were denuded of endothelium by rubbing with a metal probe in all experiments except those involving zaprinast, a cGMP phosphodiesterase inhibitor that caused little relaxation unless the endothelium was intact (12) . Rings constricted with norepinephrine (NE, 31 nM) were given acetylcholine (ACh, 10-8 to 10-5 M), which reduced tension in rings with (-90.2 ± 5.2%) but not without (-4.7 + 2.7%) endothelium. Denuded rings were constricted with KCl (80 mM) or NE (31 nM) and relaxed with 3-isobutyl-1-methylxanthine (IBMX; 0.1 mM), a cyclic nucleotide phosphodiesterase inhibitor, or authentic NO (10-8to 10-4M). The effect ofpretreatment with K-channel inhibitors tetraethylammonium (TEA, 30 mM), 4-aminopyridine (4-AP, 10 mM), or charybdotoxin (CTX, 200 nM; Calbiochem) (n -5 rings per group) on IBMX-and NOinduced relaxation was compared to control (no inhibitor) in both NE-and KCl-constricted rings. The doses of K-channel blockers used have been shown to inhibit whole-cell K current (IK) in PA VSM cells (13) . Rings were flash frozen in liquid N2 at the nadir in tension for cGMP analysis (14) . To exclude nonspecific impairment of relaxation, the effect of TEA was compared in rings relaxed with the cGMP phosphodiesterase inhibitor zaprinast (10-7 to 10-4 M), gift from Rh6ne-Poulenc Rorer, Dagenham, England, dissolved in dimethyl sulfoxide vs. papaverine (10-7 to 10-5 M), a cGMPindependent vasodilator that inhibits the voltage-gated Ca channel (15, 16) .
Electrophysiology. Enzymatically dispersed rat VSM cells were obtained from second-division PAs (13) . lK was measured at 220C using whole-cell patch-clamp technique (17) .
The microelectrodes had a 1.5-,um o.d. and a resistance of =3 Mfl (13) . The pipette solution contained 140 mM KCl, 1.0 mM MgCl2, 10 mM Hepes, 5 mM ATP (dipotassium salt), 2 mM phosphocreatine (disodium salt), and 5 mM EGTA (pH 7.2). When it became apparent that NO/cGMP-responsive Series resistance was compensated (20-60%6) using the compensation controls. In most experiments, the cell served as its own control (e.g., the IK after intervention were normalized to the IK at +70 mV under control conditions). This corrects for variations in the magnitude of IK among cells of different sizes. For cGMP, methylene blue, and okadaic acid, which were added to the patch pipette, the initial IK on penetration of the cell was considered the "control" value for normalization. In six control cells (no agents given), IK was stable for >30 min.
The effects of increasing cGMP by three strategies were studied. (i) Authentic NO (2 pM) was given close to the cell surface with perfusion suspended. (ii) cGMP was given in the patch pipette (1 mM) or in the bath solution as a membranepermeable analog, 8-bromo-cGMP (8-Br-cGMP, 2 mM) (18) . (iii) cGMP phosphodiesterase was inhibited by IBMX (0.1 mM) or zaprinast (0.2 mM).
To determine whether NO activated K channels through its ability to increase cGMP, NO was given to five cells while the patch pipette contained the guanylate cyclase inhibitor methylene blue (0.1 mM). The type of K channel activated by intracellular cGMP was characterized by noting the effects of CTX (200 nM), TEA (10 mM), and 4-AP (5 mM) on the responses to NO and 8-Br-cGMP.
To ascertain whether K-channel activation depended on cGK, NO (Fig. 5) . Approximately two-thirds of the cells had a low-noise slow-inactivating current, more sensitive to 4-AP than CTX or TEA, consistent with a major contribution by a delayed-rectifier-type K channel (Fig. 5C ). The other cells had current traces displaying spontaneous spiking and considerable inhibition ofIK by CTX or TEA, consistent with a greater contribution of Kca channels. These CTX-sensitive cells responded to NO with a rapid increase in 1K (Fig. 5A ) lasting for 15-22 min.
Pretreatment with methylene blue completely inhibited the effects of NO. The 1K elicited by the largest voltage pulse, +70 mV, was 99 ± 7% of control (methylene blue and NO) vs. 184 ± 31% (NO alone, P < 0.05). IBMX increased basal IK and this was enhanced by addition of NO (Fig. 6) (Fig. 7) or okadaic acid (Fig. 8) enhanced IK in cells with an IK dominated by Kca channels.
DISCUSSION
The major finding ofthis study is that increasing cGMP levels in VSM cells increase IK and this cGK-mediated effect is essential to NO-and cGMP-induced relaxation. IK is increased whether cGMP is elevated by activating guanylate cyclase, by inhibiting cGMP phosphodiesterase, or by direct augmentation of cGMP levels. Fig. 1 illustrates the proposed mechanism ofrelaxation utilized by NO and cGMP. Although single-channel studies of excised patches showed that exogenous cGK increases IK (9), this study defines the cGMPcGK-K-channel cascade in the whole cell and proves the functional significance of this pathway for VSM relaxation.
Endothelial-derived relaxing factor, now thought to be NO (22) , increases levels of cGMP in VSM prior to the onset of vasodilatation (1) . The link between cGMP-dependent vasodilatation and membrane potential was unclear despite evidence that depolarization inhibited the effects of endothelial-derived relaxing factor (2) [e.g., KCl impairs pulmonary vasodilatation to ACh and bradykinin (23) ]. In the current study, KCl nearly eliminates relaxation in response to NO and IBMX (Fig. 2) . The failure ofNO and IBMX to relax KCl-constricted rings is due to elimination of the chemical gradient for K efflux, not impaired cGMP synthesis (cGMP levels were similar in KCl-and NE-constricted rings).
Pharmacological blockade of K channels also inhibits cGMP-induced relaxation but does not impair the response to a cGMP-independent vasodilator, papaverine (Fig. 3) . Presumptive identification of the subtype of K channel involved is provided by the observation that CTX, a relatively specific inhibitor of KCa channels (24) , reduces NO-induced relaxation (Fig. 2) . Thus, these observations suggest that NO/ cGMP-induced relaxation is largely mediated by Kca-channel activation, although the reduction of IBMX-induced relaxation by 4-AP raises the possibility that a delayed rectifier or other K channel may also be involved.
Micropuncture measurements of membrane potential in intact vascular tissues have yielded conflicting results as to whether NO does (3) (4) (5) or does not (6, 7) cause membrane hyperpolarization. This technique does not lend itself to dissection of the intracellular pathway for cGMP-mediated hyperpolarization or identification of the subclasses of ion channels involved. Consequently, direct measurement of K-channel activity, using the patch-clamp technique, was chosen to assess the mechanism by which NO and cGMP alter VSM-cell electrophysiology. The current study defines a central role for cGMP, rather than NO itself, in K-channel activation. Focusing on cGMP makes it easier to understand how agents that elevate cGMP, such as ACh, may hyperpo- (B) Current-voltage plot (mean ± SEM; n = 4-6). * and t, P < 0.05 and P < 0.01, respectively, that the curve differs from control. larize and relax VSM without an obligatory role for NO. While NO-induced hyperpolarization is inhibited by the NO inactivator, hemoglobin, ACh-induced hyperpolarization in the same vascular rings is preserved (6, 7) . Furthermore, in the adult rat pulmonary circulation, ACh causes vasodilatation that is not inhibited by NO synthase inhibitors (25) and does not elicit NO synthesis (12 (Fig. 4) . Methylene blue's inhibition of NO-induced K-channel activation argues against a direct effect of NO on the K channel.
There is a report that GMP, rather than cGMP, increases the activity of Kca channels (27) . However, phosphodiesterase inhibition minimizes GMP production while augmenting cGMP levels and yet phosphodiesterase inhibitors cause relaxation and increase IK (Fig. 6 ). This implies that cGMP is more important than GMP in augmenting IK. The increase in IK caused by NO and cGMP requires cGK activity and is inhibited by H-8. Although cGK may directly phosphorylate the K channel, the possibility that other proteins could be important intermediary kinase targets cannot be excluded. Furthermore, H-8 is not entirely specific and may inhibit both cGK and cAMP-dependent protein kinase. The predominant role of cGK in the NO/cGMP dilator response is supported by the dramatic increase in IK caused by (Sp)-cGMP[S] (Fig. 7) , mimicking the effects of NO and cGMP. (Sp)-cGMP[S] is quite a specific activator ofcGK with minimal effects on cAMP-dependent protein kinase (20) .
Kinases modulate the activity of many intracellular proteins by enhancing phosphorylation. Homeostasis is maintained by phosphatases that dephosphorylate the target proteins, reversing the effects ofthe kinases. Okadaic acid slows dephosphorylation and increases IK in NO-sensitive cells (Fig. 8) , indicating that stabilization of protein phosphorylation is important to the basal activity of cGMP-sensitive K channels.
Limitations. Although the cGMP levels measured in rings (pmol/g of tissue) cannot be directly compared to molar cGMP concentration used in patch pipette, it is likely that we administered higher cGMP doses than occur physiologically. Nevertheless, increasing cGMP by low doses of NO or phosphodiesterase inhibition increased IK, suggesting that K channels are activated by physiologically relevant cGMP levels.
Many vasodilators increase both cGMP and cAMP production. A role for cAMP in NO-induced relaxation (28) cannot be excluded as both IBMX and H-8 have some effect on the cAMP pathway and cGK can be activated by high levels of cAMP (29) .
cGMP might also cause relaxation through its wellestablished ability to reduce cytosolic Ca2+ concentration (30) , an effect that could have been obscured by the large doses of KCl and TEA used in the current experiment. However, the relaxation caused by papaverine, which inhibits the voltage-gated Ca channel and lowers cytosolic Ca2+ concentration (16), was not inhibited by the same dose of TEA. It is probable that effects on cytosolic Ca2+ concentration and KCa channels occur in the VSM.
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